High blood sugar leads to many long-term complications, including stroke, heart disease, poor circulation, kidney failure and diabetic retinopathy
Empagliflozin
The rising incidence of Type II diabetes has sparked a real need for more, and more effective, drug treatments for the condition. Growing levels of obesity tie in with this dramatic increase in diabetes, and while about 285 million people were estimated to have the Type II form in 1985, the number was just 30 million or so a mere 25 years earlier.1
– See more at:
http://www.manufacturingchemist.com/technical/article_page/Diabetes__empagliflozin/88178
